AI assistant
CYTOKINETICS INC — Director's Dealing 2022
Feb 18, 2022
30870_dirs_2022-02-17_44a64f3d-48fb-4a1f-a367-005d703f1081.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-02-16
Reporting Person: Malik Fady Ibraham (EVP Research & Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-16 | Common Stock | A | 2773 | $0.0 | Acquired | 152087 | Direct |
| 2022-02-16 | Common Stock | A | 4375 | $0.0 | Acquired | 156462 | Direct |
Footnotes
F1: On or about May 11, 2021, the Reporting Person was granted performance-based stock units (PSUs) of the Issuer, which upon satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into fully-vested shares of common stock of the Issuer.
F2: Comprised of restricted stock units (RSUs) issued upon conversion of certain PSUs granted to the Reporting Person on May 11, 2021. The satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into RSUs of the Issuer. These RSUs will vest in whole on February 16, 2023.